Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
To assess if oral nizatidine or lisinopril alone and in combination will increase heme
oxygenase 1 (HO-1) protein concentration and activity compared to placebo in healthy
subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Adil Bharucha
Collaborators:
National Center for Research Resources (NCRR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)